# Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine

> **NCT04019184** · PHASE3 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 64 (actual)

## Conditions studied

- Cardiac Surgery
- Acute Kidney Injury

## Interventions

- **DRUG:** L-Alanyl/L-Glutamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04019184
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-18
- **Primary completion:** 2020-02-13
- **Final completion:** 2020-05-13
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04019184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04019184, "Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04019184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*